Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Suzaki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neuropediatrics|December 31, 1997
Elevated nerve growth factor levels in cerebrospinal fluid associated with progressive cortical atrophyI Suzaki, T Hara, C Tanaka, et al.
Pediatric Neurology|March 29, 2000
Communicating hydrocephalus in a patient with Gaucher's disease type 3T Shiihara, A Oka, I Suzaki, et al.
Brain & Development|July 1, 1996
Sensorineural deafness in siblings with adenosine deaminase deficiencyC Tanaka, T Hara, I Suzaki, et al.
Journal of Child Neurology|April 1, 1997
Nerve growth factor levels in cerebrospinal fluid from patients neurologic disordersI Suzaki, T Hara, Y Maegaki, et al.
Acta Paediatrica Japonica : Overseas Edition|August 1, 1994
An early-onset case of multiple sclerosis with thalamic lesions on MRIK Asai, M Inagaki, Y Maegaki, et al.
Neuropediatrics|March 17, 2006
Biphasic clinical course and early white matter abnormalities may be indicators of neurological sequelae after status epilepticus in childrenR Okamoto, S Fujii, T Inoue, et al.
Rhinology|September 26, 2024
Omalizumab reduces allergic rhinitis symptoms due to Japanese cedar pollen by improving eosinophilic inflammationK Hirano, I Suzaki, N Okuzawa, et al.
Rhinology|July 26, 2024
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and RussiaS Fujieda, C Wang, M Yoshikawa, et al.
Rhinology|September 10, 2023
Olfactory and taste dysfunctions caused by COVID-19: a nationwide studyT Miwa, E Mori, R Sekine, et al.
Rhinology|February 20, 2026
Comparative analyses of COVID-19-related olfactory dysfunction and classical post-viral olfactory dysfunction: a multicenter retrospective studyT Miwa, K Tsuzuki, I Suzaki, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neuropediatrics|December 31, 1997
Elevated nerve growth factor levels in cerebrospinal fluid associated with progressive cortical atrophyI Suzaki, T Hara, C Tanaka, et al.
Pediatric Neurology|March 29, 2000
Communicating hydrocephalus in a patient with Gaucher's disease type 3T Shiihara, A Oka, I Suzaki, et al.
Brain & Development|July 1, 1996
Sensorineural deafness in siblings with adenosine deaminase deficiencyC Tanaka, T Hara, I Suzaki, et al.
Journal of Child Neurology|April 1, 1997
Nerve growth factor levels in cerebrospinal fluid from patients neurologic disordersI Suzaki, T Hara, Y Maegaki, et al.
Acta Paediatrica Japonica : Overseas Edition|August 1, 1994
An early-onset case of multiple sclerosis with thalamic lesions on MRIK Asai, M Inagaki, Y Maegaki, et al.
Neuropediatrics|March 17, 2006
Biphasic clinical course and early white matter abnormalities may be indicators of neurological sequelae after status epilepticus in childrenR Okamoto, S Fujii, T Inoue, et al.
Rhinology|September 26, 2024
Omalizumab reduces allergic rhinitis symptoms due to Japanese cedar pollen by improving eosinophilic inflammationK Hirano, I Suzaki, N Okuzawa, et al.
Rhinology|July 26, 2024
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and RussiaS Fujieda, C Wang, M Yoshikawa, et al.
Rhinology|September 10, 2023
Olfactory and taste dysfunctions caused by COVID-19: a nationwide studyT Miwa, E Mori, R Sekine, et al.
Rhinology|February 20, 2026
Comparative analyses of COVID-19-related olfactory dysfunction and classical post-viral olfactory dysfunction: a multicenter retrospective studyT Miwa, K Tsuzuki, I Suzaki, et al.
Pageof 1